Neuroxelin dosage chart

Reconstitution steps

1. 1Allow lyophilized vial to reach room temperature before opening.
2. 2Draw 3.0 mL bacteriostatic water with a sterile syringe.
3. 3Inject slowly down the vial wall; avoid foaming.
4. 4Gently swirl/roll until dissolved (do not shake).
5. 5Label with concentration (16 mg/mL) and date; refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Dosing Cycle & Timing

This protocol runs on a 5 days on / 2 days off cycle.

• Cycle: 5 days on, 2 days off — dose Monday through Friday and rest on the weekend.
• 5 dosing days per week; the 2 off days help limit receptor desensitisation and give injection sites time to recover.
• Keep the dose time consistent on dosing days.
• If a weekday dose is missed, take it the same day if possible — do not dose on an off day to catch up.
• Weekly totals in the supplies and shopping lists are calculated on 5 dosing days, not 7.

Protocol Overview

Concise summary of the once-daily regimen for neuroprotection and cognitive recovery.

• Goal: Support neuroprotection, reduce neuroinflammation, and enhance cognitive recovery following brain injury.
• Schedule: Daily subcutaneous injections for 8–12 weeks (extend if desired).
• Dose Range: 250–1000 mcg daily; typical dose is 500 mcg.
• Reconstitution: 3.0 mL per 48 mg vial (16 mg/mL) for practical unit measurements.
• Storage: Lyophilized frozen at −20 °C; reconstituted refrigerated at 2–8 °C; use within 4 weeks of reconstitution.

Dosing Protocol

Suggested daily dosing approach with optional titration.

• Start: 500 mcg daily for Weeks 1–4; assess tolerance.
• Adjust: Increase to 750–1000 mcg daily from Week 5 if well-tolerated and more aggressive support is desired.
• Frequency: Once per day (subcutaneous), preferably morning.
• Cycle Length: 8–12 weeks; re-assess every 8 weeks for extension.
• Timing: Administer at the same time each morning; rotate injection sites.

Storage Instructions

Proper storage preserves peptide integrity and potency.

• Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable for months to years.
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 4 weeks; avoid freeze–thaw cycles.
• Allow vials to reach room temperature before opening to reduce condensation and moisture uptake.
• Consider aliquoting into sterile cryovials if not using full volume within 4 weeks.

Important Notes

Practical considerations for consistency and safety.

• Use new sterile insulin syringes for each injection; dispose in a sharps container.
• Rotate injection sites (abdomen, thighs, upper arms) to prevent tissue irritation or lipohypertrophy.
• Inject slowly; wait a few seconds before withdrawing the needle.
• Document daily dose, time, and injection site to maintain consistency.
• For doses ≤6 units, use 30- or 50-unit insulin syringes for improved measurement accuracy.

How This Works

Neuroxelin is designed to intervene in the cascade of brain injury through multiple mechanisms. It may dampen excitotoxic neuron death by disrupting NMDA receptor signaling pathways, similar to nerinetide (NA-1), which interferes with PSD-95 protein interactions. Additionally, Neuroxelin-class peptides can reduce neuroinflammation by downregulating microglial activation and cytokine release, as demonstrated in studies of apoE-mimetic peptides like CN-105. The peptide may also provide neurotrophic support by promoting synaptic repair and neurogenesis, supporting neuronal survival and vascular repair following acute brain injuries.

Potential Benefits & Side Effects

Observations from preclinical and clinical literature on related neuropeptides.

• Research suggests improved neurological outcomes and functional recovery following stroke or brain injury.
• Studies of peptide supplementation show significant improvements in cognitive test scores (MoCA) and information processing speed over 90–360 days.
• Animal studies demonstrate reduced neuronal death, decreased microglial activation, and better behavioral outcomes.
• Related peptides show low toxicity profiles with no significant difference in adverse events versus placebo in Phase III trials.
• Possible mild injection-site reactions (redness, irritation) may occur with subcutaneous administration; rotate sites to minimize.

Lifestyle Factors

Complementary strategies to support cognitive recovery.

• Combine with structured physical rehabilitation and cognitive exercises for enhanced outcomes.
• Prioritize quality sleep (7–9 hours) to support neural repair and memory consolidation.
• Maintain a nutrient-rich diet with adequate omega-3 fatty acids, antioxidants, and protein.
• Engage in regular aerobic exercise as tolerated to promote cerebral blood flow.
• Manage stress through mindfulness or relaxation techniques to support recovery.

Injection Technique

General subcutaneous guidance from clinical best-practice resources.

• Clean the vial stopper and skin with alcohol; allow to dry completely.
• Pinch a skinfold; insert the needle at 45° into subcutaneous tissue.
• Do not aspirate for subcutaneous injections; inject slowly and steadily over ~5 seconds.
• Rotate sites systematically (abdomen, thighs, upper arms) to avoid tissue irritation.
• Use room-temperature solution and allow alcohol to dry before injecting to minimize discomfort.
• Wait 2 seconds after injection before withdrawing the needle; apply gentle pressure with gauze if needed.

Important Note

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.

Neuroxelin dosage FAQs